An official company update on the NAZ app and dividend might be appreciated. I am sure you know this already. Updating the ALTuCELL acquistion and the public company purchase for NGIO etc. No need for a CC IMO, just a news release. I imagine some are wondering how this report affects the short and intermediate plan.
I personally was hoping we had the up-listing and spinout over with in Nov-Dec so we could focus on business growth in 2020.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links